Leap Therapeutics gets Nasdaq bid price extension to March 9, 2026

CYPHERPUNK TECHNOLOGIES INC.

Nasdaq granted additional 180-day compliance period until March 9, 2026, for minimum $1.00 bid price.
Initial 180-day period ended Sept. 8, 2025; company met all other listing standards except bid price.
Company may implement a reverse stock split to regain compliance.
No assurance of regaining compliance; delisting could follow if not cured by March 9, 2026.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.